True Light & ADIA Back Peptide Drug Development
01 Apr 2026
US$ 20.00
True Light Capital, a wholly owned subsidiary of Temasek Holdings (Pte) Ltd, and Abu Dhabi Investment Authority ......
Related Publications
Primavera Venture Partners, Eminence Ventures and Baidu Ventures were among returning investors in the series A+ and ......
YuanBio Venture Capital and Chengdu Science and Technology Innovation Investment Group Co Ltd have co-led the near ......
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.